Wealth Enhancement Advisory Services’s Biogen BIIB Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.27M	Buy	67,338 +4,808	+8%	+$920K	0.01%	761
2026 Q1	$6.65M	Buy	62,530 +24,582	+65%	+$4.53M	0.01%	759
2025 Q4	$7.2M	Buy	37,948 +5,041	+15%	+$824K	0.01%	841
2025 Q3	$5.01M	Buy	32,907 +5,040	+18%	+$681K	0.01%	946
2025 Q2	$3.7M	Buy	27,867 +8,818	+46%	+$1.1M	0.01%	1042
2025 Q1	$2.61M	Buy	19,049 +2,606	+16%	+$373K	0.01%	1111
2024 Q4	$2.51M	Buy	16,443 +11,504	+233%	+$1.94M	﹤0.01%	1060
2024 Q3	$957K	Sell	4,939 -1,183	-19%	-$247K	﹤0.01%	1429
2024 Q2	$1.42M	Buy	6,122 +64	+1%	+$13.9K	﹤0.01%	1132
2024 Q1	$1.31M	Sell	6,058 -433	-7%	-$101K	﹤0.01%	1118
2023 Q4	$1.68M	Sell	6,491 -5,520	-46%	-$1.36M	﹤0.01%	958
2023 Q3	$3.09M	Buy	+12,011	New	+$3.21M	0.01%	704
2023 Q2	–	Sell	-5,164	Closed	-$1.44M	–	516
2023 Q1	$1.44M	Buy	+5,164	New	+$1.43M	0.02%	262
2021 Q2	–	Sell	-4,048	Closed	-$1.1M	–	269
2021 Q1	$1.1M	Buy	4,048 +229	+6%	+$61.8K	0.02%	187
2020 Q4	$1.05M	Buy	+3,819	New	+$985K	0.02%	157
2019 Q2	–	Sell	-3,342	Closed	-$769K	–	205
2019 Q1	$769K	Sell	3,342 -705	-17%	-$222K	0.04%	154
2018 Q4	$1.37M	Buy	+4,047	New	+$1.29M	0.09%	89
2018 Q3	–	Sell	-3,812	Closed	-$1.31M	–	172
2018 Q2	$1.31M	Buy	+3,812	New	+$1.07M	0.08%	91
2017 Q3	–	Sell	-2,767	Closed	-$756K	–	144
2017 Q2	$756K	Buy	+2,767	New	+$732K	0.07%	134

Other funds holding BIIB

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

CIM

Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return

GIC

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Wealth Enhancement Advisory Services's BIIB Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Biogen (BIIB) stake by 7.7% in Q2 2026, buying an estimated $920K and bringing the position to 67,338 shares worth $8.27M. The position accounts for 0.01% of the portfolio, ranked #761.

Wealth Enhancement Advisory Services first reported a position in BIIB in Q2 2017 and has held it in 19 quarters since. 161 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Wealth Enhancement Advisory Services held 67,338 shares of Biogen worth $8.27M as of Q2 2026.
Wealth Enhancement Advisory Services bought 4,808 Biogen shares in Q2 2026, an estimated $920K.
Biogen made up 0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #761 holding.
Wealth Enhancement Advisory Services first reported a position in Biogen in Q2 2017 and has held it in 19 quarters since.
161 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.